Dr. Nir Barzilai is a leading figure in the field of geroscience, whose pioneering work has shown that aging itself has distinct biological drivers that can be targeted to prevent age-related diseases. At Albert Einstein College of Medicine, he serves as Professor of Medicine and Genetics and directs the Institute for Aging Research and BIO VITAL, the Center for Validation of Interventions Targeting Aging and Longevity.

Dr. Barzilai has published more than 360 papers and made seminal contributions to understanding the mechanisms of exceptional longevity, extending healthspan in model organisms, and identifying genetic pathways linked to healthy aging in centenarian families. He is the recipient of numerous honors, including the IPSEN Longevity Award.He co-founded and serves as President of the Academy of Geroscience and sits on the Board of Directors of the American Federation for Aging Research, where he co-leads the biomarker program (FAST, ARPA-H), the Targeting Aging with Metformin (TAME) trial, and the Super Agers initiative. He also serves on the Executive Committee of the Longevity Biotech Association, the Council of the Healthy Longevity Medicine Society, and is a Fellow of both the Association of American Physicians (AAP) and the New York Academy of Medicine. Dr. Barzilai is the author of Age Later: Health Span, Life Span, and the New Science of Longevity.